首页> 外国专利> TUMOUR TREATMENT AGENTS AND METHOD

TUMOUR TREATMENT AGENTS AND METHOD

机译：肿瘤治疗剂和方法

页面导航

摘要
著录项
相似文献

摘要

N1-(3-Methoxypropyl)-2-(pyridylmethylidene)-hydrazine-1-carbothioamide (I) and its Cu2+, Pd2+ and Pt2+ complexes are effective anti-tumor agents. Also disclosed are compositions comprising (I) and its Cu2+, Pd2+ and Pt2+ complexes, and the use of the compositions in the treatment of malignant tumors.

机译：N1-（3-甲氧基丙基）-2-（吡啶基亚甲基）-肼-1-甲硫酰胺（I）及其Cu2 +，Pd2 +和Pt2 +复合物是有效的抗肿瘤剂。还公开了包含（I）及其Cu 2+，Pd 2+和Pt 2+复合物的组合物，以及该组合物在治疗恶性肿瘤中的用途。

著录项

公开/公告号EP2512473A1

专利类型
公开/公告日2012-10-24

原文格式PDF
申请/专利权人 VIVOLUX AB;
展开▼

申请/专利号EP20100837961
发明设计人 LARSSON ROLF;NYGREN PETER;GULLBO JOAKIM;WESTMAN GUNNAR;
展开▼

申请日2010-12-08
分类号A61K31/4402;A61P35;C07D213/53;
国家 EP
入库时间 2022-08-21 17:11:26

相似文献

专利
外文文献
中文文献

1. Treatment of Wet FGD Wastewater by a Modified Chemical Precipitation Method Using a Solid Powder Reagent [J] . Yong Kang, Jia Lu, Jing Guo 天津大学学报（英文版） . 2017,第002期

2. Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis. [J] . De Filippis L, Caliri A, Anghelone S, Panminerva medica . 2006,第2期

3. Anti-tumour necrosis factor agents and tuberculosis risk: is there a difference? What are the most appropriate screening methods? [J] . Hagel S, Stallmach A Zeitschrift fur Gastroenterologie . 2010,第7期

4. Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice [J] . L-M Ching, S Zwain, B C Baguley British Journal of Cancer . 2004,第4期

5. Comparison of FDTD and FE Methods in Numerical Dosimetry for the Treatment of Cancerous Tumours with Electromagnetic Fields [C] . N. Siauve, M.M. Paulides, L. Nicolas, Compumag Conference on the Computation of Electromagnetic Fields vol.2; 20050626-30; Shenyang(CN) . 2005

6. Mechanisms of tumour cell death induced by novel titanium-based agents. [D] . Chan, Marina. 2007

7. Updated consensus statement on biological agents specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra) for the treatment of rheumatic diseases 2005 [O] . D Furst, F Breedveld, J Kalden, 2005

8. Increased Serum Tumour Necrosis Factor- in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor- Agents? [O] . L Matusiak, A Bieniek, JC Szepietowski 2009

9. Analysis of Specialized Pesticide Problems Invertebrate Control Agents - Efficacy Test Methods. Volume Ⅲ. General Soil Treatments [R] . Mahlon Fair child, Christian C. Burkhardt, Gerald Mustek 1977

1. Development and Application of a Validated UHPLC Method for the Determination of Atropine and Its Major Impurities in Antidote Treatment Nerve Agent Auto-Injectors (ATNAA) Stored in the Strategic National Stockpiles [J] . Cheng H. Yen ,Adil Mohammad ,Miah Schneider . 药理与制药（英文） . 2017,第1期

2. A Method and a Surface Treatment Agent for Preventing Biofouling on Surfaces under Water [J] . . 化学与化工 . 2012,第003期

3. Time to give up traditional methods for the management of gastrointestinal neuroendocrine tumours [J] . Ahmet Yozgat ,Murat Kekilli ,Mustafa Altay . 世界临床病例杂志 . 2021,第029期

4. A Combination of Antigen Retrieval Methods Significantly Enhances the Unmasking of Tedious Antigens of Lymphangiogenesis and Angiogenesis in Canine Mammary Tumour [J] . Parmeet Pal Singh ,Naresh Kumar Sood . 生物科学与医学（英文） . 2017,第12期

5. 基于临床实验细胞学兽医可以诊断哪些肿瘤探讨肿瘤治疗剂量的一个病例分析 [C] . Kurt R Verkest ,Kurt ,Jennifer L Brazzell . 第五届中国小动物医师大会 . 2016

6. 新型光热治疗剂用于肿瘤热疗的增效研究 [A] . 周俊红 . 2019